Gliosarcoma : The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations
Copyright © 2022 Chuan-dong Cheng et al..
Gliosarcoma (GSM), a histologic variant of glioblastoma (GBM), carries a poor prognosis with less than one year of median survival. Though GSM is similar with GBM in most clinical and pathological symptoms, GBM has unique molecular and histological features. However, as the rarity of GSM samples, the genetic information of this tumor is still lacking. Here, we take a comprehensive analysis of DNA copy number variations (CNV) in GBM and GSM. Whole genome sequencing was performed on 21 cases of GBM and 15 cases of GSM. CNVKIT is used for CNV calling. Our data showed that chromosomes 7, 8, 9, and 10 were the regions where CNV frequently happened in both GBM and GSM. There was a distinct CNV signal in chromosome 2 especially in GSM. The pathway enrichment of genes with CNV was suggested that the GBM and GSM shared the similar mechanism of tumor development. However, the CNV of some screened genes displayed a disparate form between GBM and GSM, such as AMP, BEND2, HDAC6, FOXP3, ZBTB33, TFE3, and VEGFD. It meant that GSM was a distinct subgroup possessing typical biomarkers. The pathways and copy number alterations detected in this study may represent key drivers in gliosarcoma oncogenesis and may provide a starting point toward targeted oncologic analysis with therapeutic potential.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2022 |
---|---|
Enthalten in: |
Analytical cellular pathology (Amsterdam) - 2022(2022) vom: 07., Seite 2376288 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cheng, Chuan-Dong [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 28.06.2022 Date Revised 16.07.2022 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1155/2022/2376288 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342780212 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342780212 | ||
003 | DE-627 | ||
005 | 20231226014916.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1155/2022/2376288 |2 doi | |
028 | 5 | 2 | |a pubmed24n1142.xml |
035 | |a (DE-627)NLM342780212 | ||
035 | |a (NLM)35757013 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cheng, Chuan-Dong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Gliosarcoma |b The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.06.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Chuan-dong Cheng et al. | ||
520 | |a Gliosarcoma (GSM), a histologic variant of glioblastoma (GBM), carries a poor prognosis with less than one year of median survival. Though GSM is similar with GBM in most clinical and pathological symptoms, GBM has unique molecular and histological features. However, as the rarity of GSM samples, the genetic information of this tumor is still lacking. Here, we take a comprehensive analysis of DNA copy number variations (CNV) in GBM and GSM. Whole genome sequencing was performed on 21 cases of GBM and 15 cases of GSM. CNVKIT is used for CNV calling. Our data showed that chromosomes 7, 8, 9, and 10 were the regions where CNV frequently happened in both GBM and GSM. There was a distinct CNV signal in chromosome 2 especially in GSM. The pathway enrichment of genes with CNV was suggested that the GBM and GSM shared the similar mechanism of tumor development. However, the CNV of some screened genes displayed a disparate form between GBM and GSM, such as AMP, BEND2, HDAC6, FOXP3, ZBTB33, TFE3, and VEGFD. It meant that GSM was a distinct subgroup possessing typical biomarkers. The pathways and copy number alterations detected in this study may represent key drivers in gliosarcoma oncogenesis and may provide a starting point toward targeted oncologic analysis with therapeutic potential | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Chen, Cheng |e verfasserin |4 aut | |
700 | 1 | |a Wang, Li |e verfasserin |4 aut | |
700 | 1 | |a Dong, Yong-Fei |e verfasserin |4 aut | |
700 | 1 | |a Yang, Yang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yi-Nan |e verfasserin |4 aut | |
700 | 1 | |a Niu, Wan-Xiang |e verfasserin |4 aut | |
700 | 1 | |a Wang, Wen-Chao |e verfasserin |4 aut | |
700 | 1 | |a Liu, Qing-Song |e verfasserin |4 aut | |
700 | 1 | |a Niu, Chao-Shi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Analytical cellular pathology (Amsterdam) |d 2010 |g 2022(2022) vom: 07., Seite 2376288 |w (DE-627)NLM202563650 |x 2210-7185 |7 nnns |
773 | 1 | 8 | |g volume:2022 |g year:2022 |g day:07 |g pages:2376288 |
856 | 4 | 0 | |u http://dx.doi.org/10.1155/2022/2376288 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2022 |j 2022 |b 07 |h 2376288 |